M
Massimo Valerio
Researcher at University Hospital of Lausanne
Publications - 137
Citations - 3826
Massimo Valerio is an academic researcher from University Hospital of Lausanne. The author has contributed to research in topics: Prostate cancer & Medicine. The author has an hindex of 24, co-authored 90 publications receiving 2760 citations. Previous affiliations of Massimo Valerio include University College London Hospitals NHS Foundation Trust & University College London.
Papers
More filters
Journal ArticleDOI
Guidelines for perioperative care after radical cystectomy for bladder cancer: Enhanced Recovery After Surgery (ERAS(®)) society recommendations.
Yannick Cerantola,Massimo Valerio,Beata Persson,Patrice Jichlinski,Olle Ljungqvist,Martin Hübner,Wassim Kassouf,Stig Müller,Gabriele Baldini,Francesco Carli,Torvind Naesheimh,Lars M. Ytrebø,Arthur Revhaug,Kristoffer Lassen,Tore Knutsen,Erling Aarsether,Peter Wiklund,Hitendra R.H. Patel +17 more
TL;DR: ERAS has not yet been widely implemented in urology and evidence for individual interventions is limited or unavailable and the experience in other surgical disciplines encourages the development of an ERAS protocol for cystectomy.
Journal ArticleDOI
Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging–Ultrasound Fusion Targeted Biopsy: A Systematic Review
Massimo Valerio,Massimo Valerio,Massimo Valerio,Ian Donaldson,Mark Emberton,Mark Emberton,Behfar Ehdaie,Boris Hadaschik,Leonard S. Marks,Pierre Mozer,Ardeshir R. Rastinehad,Hashim U. Ahmed,Hashim U. Ahmed +12 more
TL;DR: Software-based MRI-US fusion targeted biopsy seems to detect more clinically significant cancers deploying fewer cores than standard biopsy, although further high-quality evidence is needed to change current practice.
Journal ArticleDOI
The role of focal therapy in the management of localised prostate cancer: a systematic review
Massimo Valerio,Massimo Valerio,Hashim U. Ahmed,Mark Emberton,Nathan Lawrentschuk,Massimo Lazzeri,Rodolfo Montironi,Paul L. Nguyen,John Trachtenberg,Thomas J. Polascik +9 more
TL;DR: A systematic review highlights that, when focal therapy is delivered with intention to treat, the perioperative, functional, and disease control outcomes are encouraging within a short- to medium-term follow-up.
Journal ArticleDOI
New and Established Technology in Focal Ablation of the Prostate: A Systematic Review
Massimo Valerio,Massimo Valerio,Massimo Valerio,Yannick Cerantola,Scott E. Eggener,Herbert Lepor,Thomas J. Polascik,Arnauld Villers,Mark Emberton,Mark Emberton +9 more
TL;DR: There is high evidence that focal therapy is safe and has low detrimental impact on continence and potency, and oncological effectiveness is yet to be defined against standard of care.
Journal ArticleDOI
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies
Giorgio Gandaglia,Guillaume Ploussard,Massimo Valerio,Agostino Mattei,Cristian Fiori,Nicola Fossati,Armando Stabile,Jean Baptiste Beauval,Bernard Malavaud,Mathieu Roumiguié,Daniele Robesti,Paolo Dell'Oglio,Marco Moschini,Stefania Zamboni,Arnas Rakauskas,Francesco De Cobelli,Francesco Porpiglia,Francesco Montorsi,Alberto Briganti +18 more
TL;DR: The first nomogram to predict lymph node invasion (LNI) in prostate cancer patients diagnosed via magnetic resonance imaging-targeted biopsy undergoing radical prostatectomy is developed.